Advertisement

Dexamethasone suppression test in senile dementia of the Alzheimer type

  • P. Davous
  • M. Roudier
  • Y. Lamour
  • H. Susini de Luca
  • C. Abramowitz
Part of the Advances in Behavioral Biology book series (ABBI, volume 29)

Abstract

The dexamethasone suppression test (DST) has been widely studied in depressive patients. According to Carroll (1), the average sensitivity of this test is 45% among depressed patients irrespective of the etiology of the depression. Little is known about DST results in dementia of the Alzheimer type (SDAT) and in non demented elderly patients and there are conflicting results in the literature (2–6). The purpose of the present investigation was to determine the frequency of abnormal DST responses in a population of elderly inpatients affected with SDAT compared to a group of control mentally healthy patients of similar age range.

Keywords

Alzheimer Type Senile Dementia Dexamethasone Suppression Test Beta Endorphin Elderly Inpatient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    B.J. Carroll, The Dexamethasone Suppression Test for Melancholia, Brit.J.Psychiat. 140, 292 - 304 (1982).PubMedCrossRefGoogle Scholar
  2. 2.
    M. Raskind, E. Peskind, M.F. Rivard, R. Veith, R.Barnes, Dexamethasone suppression test and Cortisol circadian rhythm in primary degenerative dementia, Am.J.Psychiatry. 139, 1468–1471 (1982).PubMedGoogle Scholar
  3. 3.
    J.E. Spar, R. Gerner, Does the dexamethasone suppression test distinguish dementia from depression ? Am.J.Psychiatry. 139, 238–240 (1982)PubMedGoogle Scholar
  4. 4.
    J. Bâlldin, C.G. Gottfries, I. Karlsson, G. Lindstedt, G. Langstrom, J.Walinder, Dexamethasone Suppression Test and serum prolactin in dementia disorders, Brit.J.Psychiat. 143, 277–281 (19and3)Google Scholar
  5. 5.
    A. Coppen, M. Abou-Saleh, P. Milln, M. Metcalfe, J. Harwood; J. Bailey, Dexamethasone suppression test in depression and other psychiatric illness, Brit.J.Psychiat. 142, 498–504 (1983)PubMedCrossRefGoogle Scholar
  6. 6.
    M.A. Jenike, M.S. Albert, The Dexamethasone suppression test in patients with presenile and senile dementia of the Alzheimer type, J.Am.Geriat.Soc. 32, 441–444 (1984)PubMedGoogle Scholar
  7. 7.
    American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. DSM III, Third Ed. Washington (1980)Google Scholar
  8. 8.
    M.F. Folstein, S.E. Folstein, P.R. Mta Hugh, Mini Mental State. A practical method for grading the cognitive state of patients for the clinician, J.Psychiat.Res. 12, 189–198 (1975)PubMedCrossRefGoogle Scholar
  9. 9.
    L.Covi, R.S. Lipiaan, D.M. Mc Nan, T. Czerlinsky, Symptomatic volunteers in multicenter drug trials, Prog.Neuropsychopharmacol. 3, 521–533 (1979)CrossRefGoogle Scholar
  10. 10.
    M.A. Schlesser, G. Winokur, B.M. Sherman, Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic pituitary adrenal axis activity, Lancet, 1, 739–741 (1979)PubMedCrossRefGoogle Scholar
  11. 11.
    G.M. Asnis, E.J. Sachar, U. Halbreich,R.S. Nathan, H. Novacenko, L.C. Ostrow, Cortisol secretion in relation to age in major depression, Psychosom.Med. 43, 235–242 (1981)PubMedGoogle Scholar
  12. 12.
    B.J. Carroll, M. Feinberg, J.F. Greden, J. Tarika, A.A. Albala, R.F. Haskett, N. Mc James, Z.Kronfol, N. Lohr, M. Steiner, J.P. de Vigne, E. Young, A specific laboratory test for the diagnosis of melancholia, Arch.Gen.Psychiatry, 38, 15–22 (1981)Google Scholar
  13. 13.
    G.F. Oxenkrug, N.Pomara, I.M. Mc Intyre, R. J. Branconnier, M. Stanley, S. Gershon, Aging and Cortisol resistance to suppression by dexamethasone: a positive correlation, Psychiatry Research, 10, 125–130 (1983)Google Scholar
  14. 14.
    K.L. Davis, B.M. Davis, A.A. Mathé, R.C. Mohs, A.B. Roth- pearl, M.I. Levy, L.K. Gorman, P. Berger, Age and the dexamethasone suppression test in depression, Am.J.Psychiatry, 141, 872–874 (1984)PubMedGoogle Scholar
  15. 15.
    M.F. Tourigny-Rivard, M.Raskind, D. Rivard, The dexamethasone suppression test in an elderly population, Biological Psychiatry, 16, 1177–1184 (1981)PubMedGoogle Scholar
  16. 16.
    M. Friedman, M.F. Green, D.E. Sharland, Assessment of hypo- thalamic-pituitary-adrenal function in the geriatric age group, J.Gerontol. 24, 292–297 (1969)PubMedGoogle Scholar
  17. 17.
    M.T. Jones, E. Hillhouse, J. Burden, Secretion of corticotropin releasing hormone in vitro, in: Frontiers in Neuroendo- crinology, L. Martini and W.F.Ganong Eds, Raven, New York, vol 4, 195–226 (1976)Google Scholar
  18. 18.
    E.J. Sachar, G.M. Asnis, R.S. Nathan, U. Halbreich, M.A. Tabrizi, Dextroamphetamine and Cortisol in depression, Arch. Gen.Psychiatry, 37, 755–757 (1980)PubMedGoogle Scholar
  19. 19.
    B.M. Davis, K.L. Davis, Cholinergic mechanisms and anterior pituitary hormone secretion, Biol. Psychiat. 15, 303–310 (1980)PubMedGoogle Scholar
  20. 20.
    S.C. Risch, R.M. Cohen, D.S. Janowsky, N.H. Kalin, D.L. Murphy, Mood and behavioral effects of physostigmine in humans are accompanied by elevations in plasma beta endorphin and Cortisol, Science, 209, 1545–1546 (1980)PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • P. Davous
    • 1
  • M. Roudier
    • 2
  • Y. Lamour
    • 3
  • H. Susini de Luca
    • 1
  • C. Abramowitz
    • 2
  1. 1.Sainte Anne HospitalParisFrance
  2. 2.Ch.Richet HospitalVilliers le BelFrance
  3. 3.INSERM U 161ParisFrance

Personalised recommendations